Swiss Economy Surges on Pharma Growth Amid Inflation Concerns

Switzerland's economy surged in the second quarter of 2026, growing at its fastest pace in nearly five years. The country's gross domestic product expanded by 1.5%, up from 0.5% in the previous quarter, with the government attributing this growth to a significant rebound in the chemicals and pharmaceuticals sector.

A 10.5% jump in chemicals and pharmaceuticals drove this increase, fueled by stronger exports and sales. This boost was not limited to just one area of the economy, as manufacturing showed moderate growth and services experienced modest but broad-based expansion.

However, there is a catch - inflation picked up again in August, with prices doubling from previous levels due to higher fuel costs. As a result, economists are warning that the Swiss National Bank (SNB) may raise interest rates earlier than expected, potentially affecting financial conditions for companies and households.